| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.434 | 7.339 | 5.831 | 7.249 | 8.428 | 14.466 | 30.862 | 32.597 | 13.168 | 13.314 |
| Total Income - EUR | 5.448 | 7.340 | 5.831 | 7.249 | 8.445 | 14.467 | 30.869 | 32.606 | 37.440 | 37.453 |
| Total Expenses - EUR | 4.426 | 5.893 | 5.127 | 5.848 | 6.557 | 5.506 | 8.585 | 9.346 | 12.721 | 19.804 |
| Gross Profit/Loss - EUR | 1.022 | 1.447 | 704 | 1.401 | 1.889 | 8.961 | 22.284 | 23.260 | 24.719 | 17.650 |
| Net Profit/Loss - EUR | 859 | 1.226 | 646 | 1.317 | 1.804 | 8.817 | 21.975 | 23.097 | 24.603 | 14.886 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medvicol Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 6.495 | 3.525 | 4.170 | 4.169 | 6.252 | 13.869 | 22.560 | 24.156 | 40.290 | 19.541 |
| Inventories | 2.721 | 2.218 | 2.912 | 3.040 | 2.185 | 2.260 | 197 | 0 | 0 | 0 |
| Receivables | 17 | 337 | 0 | 569 | 1.553 | 0 | 4.043 | 0 | 1.105 | 4.021 |
| Cash | 3.757 | 970 | 1.258 | 560 | 2.515 | 11.609 | 18.321 | 24.156 | 39.185 | 15.520 |
| Shareholders Funds | 11.613 | 1.271 | 1.895 | 3.177 | 4.920 | 13.644 | 22.016 | 23.145 | 38.828 | 17.713 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | -5.118 | 2.254 | 2.276 | 992 | 1.332 | 225 | 544 | 1.011 | 1.462 | 1.828 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Medvicol Srl